Longboard Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Cash & Equivalents	-	593,755	195,737	150,412	97,132	400,875	Upgrade
Investment Securities	-	1,144,567	1,064,865	830,757	709,299	675,765	Upgrade
Total Investments	-	1,144,567	1,064,865	830,757	709,299	675,765	Upgrade
Gross Loans	-	3,450,186	3,432,983	2,899,237	2,390,515	2,125,954	Upgrade
Net Loans	-	3,450,186	3,432,983	2,899,237	2,390,515	2,125,954	Upgrade
Property, Plant & Equipment	-	24,964	23,240	20,789	19,288	18,757	Upgrade
Accrued Interest Receivable	-	-	30,980	23,950	20,166	20,136	Upgrade
Restricted Cash	-	-	173,337	417,355	588,715	165,224	Upgrade
Other Current Assets	-	-	8,438	2,395	12,643	8,738	Upgrade
Long-Term Deferred Tax Assets	-	-	22,607	21,394	22,323	20,107	Upgrade
Other Real Estate Owned & Foreclosed	-	-	-	639.66	639.66	4,141	Upgrade
Other Long-Term Assets	-	327,599	198,753	211,436	158,954	189,335	Upgrade
Total Assets	-	5,541,071	5,150,940	4,578,366	4,019,674	3,629,033	Upgrade
Interest Bearing Deposits	-	4,108,623	3,375,963	2,855,202	2,568,424	2,201,448	Upgrade
Non-Interest Bearing Deposits	-	-	469,893	506,000	365,071	357,253	Upgrade
Total Deposits	-	4,108,623	3,845,857	3,361,202	2,933,495	2,558,701	Upgrade
Current Portion of Long-Term Debt	-	-	145,017	199,213	165,862	226,719	Upgrade
Accrued Interest Payable	-	-	19,426	18,303	13,110	14,508	Upgrade
Other Current Liabilities	-	-	13,944	11,446	8,442	6,618	Upgrade
Long-Term Debt	-	537,036	331,097	290,899	307,370	286,510	Upgrade
Other Long-Term Liabilities	-	247,056	163,523	147,257	111,130	100,971	Upgrade
Total Liabilities	-	4,892,714	4,518,864	4,028,320	3,539,410	3,194,026	Upgrade
Common Stock	-	7,791	7,783	7,759	7,747	7,734	Upgrade
Additional Paid-In Capital	-	-	187,707	185,285	184,440	183,592	Upgrade
Retained Earnings	-	-	423,984	345,448	277,644	234,172	Upgrade
Comprehensive Income & Other	-	640,566	12,602	11,555	10,433	9,509	Upgrade
Shareholders' Equity	648,357	648,357	632,076	550,046	480,264	435,007	Upgrade
Total Liabilities & Equity	-	5,541,071	5,150,940	4,578,366	4,019,674	3,629,033	Upgrade
Total Debt	537,036	537,036	476,114	490,112	473,232	513,228	Upgrade
Net Cash (Debt)	56,719	56,719	-280,377	-339,700	-376,100	-112,353	Upgrade
Net Cash Per Share	72.78	72.78	-360.20	-437.61	-485.06	-153.23	Upgrade
Filing Date Shares Outstanding	779.45	778.89	778.32	775.9	774.66	773.37	Upgrade
Total Common Shares Outstanding	779.45	778.89	778.32	775.9	774.66	773.37	Upgrade
Book Value Per Share	832.42	832.42	812.10	708.92	619.96	562.48	Upgrade
Tangible Book Value	648,357	648,357	632,076	550,046	480,264	435,007	Upgrade
Tangible Book Value Per Share	832.42	832.42	812.10	708.92	619.96	562.48	Upgrade

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.